Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

NCT00891475 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

PROCEDURE: Radiofrequency ablation; Interferon-alpha
PROCEDURE: Radiofrequency ablation; Sunitinib maleate
DRUG: Sunitinib maleate

Sponsor

Kidney Cancer Research Bureau